Our Administrative Core (Core A) is responsible for organizing program activities and facilitating communication and interaction among core directors, scientific staff, external core users, interacting Institutes, advisory committees, and NIGMS. Its administrative structure provides oversight of the program as a whole, as well as individual cores. Pis, mentors, trainees, and staff. """"""""Core A"""""""" will also oversee budgets for the program and its constituent elements to ensure appropriate use of resources to achieve scientific and programmatic goals. In addition. Core A will provide oversight of program operations to ensure compliance with all biomedical research regulations and guidelines at the institutional, state, federal and NIH levels. The core will promote interactions among cores, their staff, MMCRI, and our regional scientific community at large. Core A also will administer training and mentorship programs to promote career development and institutional growth to sustainability. The PI of this COBRE, D Wojchowski, is also PI of Core A. The PI will work closely with the co-lnvestigator (L Oxburgh), the Program Coordinator (E Jachimowicz) and the Administrative Coordinator (M Sullivan) to manage the day-to-day operations of this program. The PI will also work closely with other center directors (including the PI of our Phase-Ill COBRE in Vascular Biology, R Friesel) to ensure that all cores work in unison with maximum benefit to all investigators and research programs without significant duplication or overlap. In Phase-Ill, this administrative structure will advance 6 prime goals: 1/ Enable and guide productive interactions among subcomponents, constituents, our parent Institute and Medical Center, and regional plus national partners and collaborators;2/Actively engage members of its expert lAC/ISC and EAC boards in order to steer science. Core Facilities, new investigator recruitments, and resources along impacting courses;3/ Effectively mentor investigators, new recruits, fellows, research staff and students;4/ Guide the continued development of productive Core Facilities that advance success in our science, recruiting, publications and Center growth towards Center self sustainability;5/ Continue to provide for an outstanding Invited Seminar Series, a new workshop in Progenitor Cell Isolation and Analysis, and joint symposium in Stem &Progenitor cell Biology;6/ Implement a highly competitive Pilot Project Program including a defined translational component.

Public Health Relevance

The Administrative Core first will facilitate and enable interactions among core directors, core personnel, end- users and collaborating institutes. This core also will oversee our pilot project program, seminar series, summer symposium, and Progenitor Cell Analysis workshop. Administrative structure will be in place to ensure regulatory compliance, evaluation, and reporting on all aspects of the program. Together, this will ensure optimal utilization of all core and program resources

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
5P30GM106391-02
Application #
8725703
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2014-06-01
Budget End
2015-05-31
Support Year
2
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Maine Medical Center
Department
Type
DUNS #
City
Portland
State
ME
Country
United States
Zip Code
04102
Farrell, Mariah L; Reagan, Michaela R (2018) Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma. Front Endocrinol (Lausanne) 9:218
Ryzhov, Sergey; Robich, Michael P; Roberts, Daniel J et al. (2018) ErbB2 promotes endothelial phenotype of human left ventricular epicardial highly proliferative cells (eHiPC). J Mol Cell Cardiol 115:39-50
Yang, Xuehui; Gong, Yan; He, Qing et al. (2018) Loss of Spry1 attenuates vascular smooth muscle proliferation by impairing mitogen-mediated changes in cell cycle regulatory circuits. J Cell Biochem 119:3267-3279
Zaidi, Mone; Lizneva, Daria; Kim, Se-Min et al. (2018) FSH, Bone Mass, Body Fat, and Biological Aging. Endocrinology 159:3503-3514
Zaidi, Mone; Yuen, Tony; Sun, Li et al. (2018) Regulation of Skeletal Homeostasis. Endocr Rev 39:701-718
Sitarski, Anna M; Fairfield, Heather; Falank, Carolyne et al. (2018) 3d Tissue Engineered In Vitro Models Of Cancer In Bone. ACS Biomater Sci Eng 4:324-336
Fairfield, Heather; Falank, Carolyne; Harris, Elizabeth et al. (2018) The skeletal cell-derived molecule sclerostin drives bone marrow adipogenesis. J Cell Physiol 233:1156-1167
Stohn, J P; Martinez, M E; Zafer, M et al. (2018) Increased aggression and lack of maternal behavior in Dio3-deficient mice are associated with abnormalities in oxytocin and vasopressin systems. Genes Brain Behav 17:23-35
Guntur, Anyonya R; Gerencser, Akos A; Le, Phuong T et al. (2018) Osteoblast-like MC3T3-E1 Cells Prefer Glycolysis for ATP Production but Adipocyte-like 3T3-L1 Cells Prefer Oxidative Phosphorylation. J Bone Miner Res 33:1052-1065
Ji, Yaoting; Liu, Peng; Yuen, Tony et al. (2018) Epitope-specific monoclonal antibodies to FSH? increase bone mass. Proc Natl Acad Sci U S A 115:2192-2197

Showing the most recent 10 out of 82 publications